Researchers from The University of Manchester, a branch of the Manchester Cancer Research Centre, have verified the potential of a drug that enhances the overall effectiveness of radiotherapy in halting tumor growth and progression. Utilizing the body's own immune system to attack tumor cells has b...

Based on a Kaiser Permanente study published online in JAMA Dermatology, radiation treatment could help lead to a decrease in the recurrence of Merkel cell carcinoma, a rare and aggressive skin cancer, while chemotherapy appears to have no lasting impact or effect on the disease's recurrence or pati...

According to a recent study, since there has been a growing interest in utilizing the body's own immune system to combat tumor cells, a method that has the possibility of being very effective without the side effects typically caused by standard chemotherapy has been discovered. Skin cancers have b...

Based on a new study, an old concept of re-treating lung tumors has come back into the fold, this time with modern technology on its side. The Comprehensive Cancer Center of Wake Forest Baptist Medical Center is one of only several cancer centers that is trying to give lung cancer patients out of t...

Based on a recent study by researchers from the Perelman School of Medicine at the University of Pennsylvania, playing an active role in their radiation treatment decisions puts cancer patients at ease and has them feeling more satisfied with their care, and may even alleviate psychological dist...

Based on a recent study, researchers at the UT Southwestern Medical Center have exhibited in both cancer cell lines and in mice that blocking vital DNA repair mechanisms could improve the overall efficiency of radiation therapy (RT) for often fatal brain tumors known as glioblastomas. RT leads to...

Based on research that was presented at the Society of Interventional Radiology's 39th Annual Scientific Meeting, minimally invasive treatment that delivers cancer-killing radiation directly to tumors shows major promise in treating breast cancer that has moved to the liver, when no other treatmen...

According to a recent study, provisional analysis of the intergroup EORTC-LYSA-FIL 20051 H10 trial published in the Journal of Clinical Oncology points to an increased risk of early relapse when eliminating radiotherapy in early PET scan negative patients with stage I/II Hodgkin's lymphoma. Early ...

A new study led by Alexey Ryazanov, a professor of pharmacology at Rutgers Robert Wood Johnson Medical School and member of the Rutgers Cancer Institute of New Jersey, suggests finding a way to make chemotherapy and radiation more effective as cancer treatments than they currently are, in addition...

According to a recent study conducted by Manchester researchers, has proven to reveal promising results for a new treatment option in follicular lymphoma. Follicular lymphoma is a kind of non-Hodgkin's lymphoma, a blood cancer, that typically develops slowly. The majority of patients are diagnos...